AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
(From Business Times (Malaysia))
Byline: Zaidi Isham Ismail
DRUG and biotechnology firm Inno Biologics Sdn Bhd expects to clinch up to RM44.4 million worth of deals involving foreign pharmaceutical companies by year-end.
Chief executive officer Dr Mohd Nazlee Kamal said Inno Biologics will be talking to three American firms and one Swiss firm next month.
Mohd Nazlee said talks will be held at the world's largest biotechnology conference, Biotechnology Industry Organisations International Convention (Bio 2006) in Chicago, the US.
Over 20,000 participants from more than 60 countries are expected to attend the event.